Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent
Alexa Kaufer, Torsten Theis, Katherine A. Lau, Joanna L Gray, William D. Rawlinson
Topics & Concepts
BiosafetyCase fatality rateInterimMedicinePandemicEpidemiologyTransmission (telecommunications)DiseaseEnvironmental healthPublic healthOutbreakIntensive care medicineMortality rateCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)VirologyPathologyInternal medicineGeographyElectrical engineeringArchaeologyEngineeringSARS-CoV-2 and COVID-19 ResearchViral Infections and Outbreaks ResearchCOVID-19 Clinical Research Studies